Description de l'entreprise
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
Conseil d'administration & Conseil de surveillance
| PDG |
| Dr. Martine A. Rothblatt |
| Conseil d'administration |
| James C. Edgemond, Michael Benkowitz, Paul A. Mahon |
| Conseil de surveillance |
| Dr. Martine A. Rothblatt, Christopher Causey, Christopher Patusky, Dr. Judy D. Olian, Linda Maxwell, M.D., Louis Sullivan, Nilda Mesa, Prof. Raymond Dwek, Ray Kurzweil, Richard Giltner, Tommy G. Thompson, Jan Malcolm |
Données de l'entreprise
| Nom: |
United Therapeutics Corporation |
| Adresse: |
1000 Spring Street,Silver Spring, Maryland 20910, USA |
| Téléphone: |
+1-301-608-9292 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.unither.com/index |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
17/06/1999 |
Relations avec les investisseurs
| Nom: |
- |
| Téléphone IR: |
+1-301-608-9292 |
| IR-Fax: |
- |
| E-mail IR: |
-
|
